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Two variant subpopulations of murine fibrosarcoma cells that differ significantly in their malignant potential 
and normal mouse fibroblasts were compared with regard to ability to respond chemotactically to collagen, colla- 
gen-derived peptides and the C5-derived tumor cell chemotactic peptide. Two distinct patterns of responsiveness 
were observed. The normal fibroblasts and non-metastasizing fibrosarcoma cells responded to the collagen prod- 
ucts but not the C5 peptide. The metastasizing fibrosarcoma cells responded to the C5 peptide but not to the col- 
lagen products. These findings emphasize the similarities between the normal fibroblasts and the non-metastasiz- 
ing fibrosarcoma cells.  
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1. I n t r o d u c t i o n  
We have previously  r e p o r t e d  tha t  a n u m b e r  
o f  t u m o r  cell lines, including the  Walker 256 
carc inosarcoma,  the  Nov iko f f  hepa toma ,  a 
mur ine  m a s t o c y t o m a  and a mur ine  l y m p h o -  
blastoid line, all d e m o n s t r a t e  chemo tac t i c  
responsiveness to  a p r o d u c e  of  the  f i f th  com-  
p l e m e n t  o f  c o m p o n e n t  (C5) ( R o m u a l d e z  
and Ward, 1975 ,  1976;  Romua ldez  et a l . ,  
1976;  Orr  et  al., 1978a ,  b) .  In a r ecen t  s tudy  
it was shown tha t  a spon taneous ly  metastasiz-  
ing mur ine  f ib rosa rcoma  variant  also respond-  
ed chemotac t i ca l ly  to  the  C5 f ac to r  bu t  t ha t  
a non-metas tas iz ing  variant  isolated f r o m  the  
same t u m o r  did no t .  L ike  the  non-metas tas iz-  
ing f ib rosa rcoma cells, no rma l  mouse  f ibro-  
blasts also failed to  r e spond  to  the  chemo-  
tact ic  f ac to r  (Orr  e t  al., 1981) .  
In the  present  s t udy  the  chemotac t i c  
response  o f  these  same metastas iz ing and non-  
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metastas iz ing f ib rosa rcoma cells and normal  
f ibroblasts  to  collagen and collagen degrada- 
t ion  p roduc t s  was examined  and co m p ared  
wi th  the  response  to  the  C5 chemotac t i c  pep-  
t ide.  Th e  results indicate  two  dis t inct  pa t te rns  
o f  d i f fe ren t ia t ion .  In one  pa t t e rn ,  exhib i ted  
b y  the  normal  f ibroSlasts  and non-metas tas iz-  
ing f ib rosarcoma cells, response  to  the  colla- 
gen pept ides  bu t  no t  the  C5 pep t ide  occurs .  
In the  o th e r  pa t t e rn ,  exh ib i ted  b y  the  metas-  
tasizing f ib rosarcoma cells, response  to  the  
C5 pep t ide  b u t  n o t  the  collagen pept ides  
occurs .  
2. Materials and m e t h o d s  
2.1. Cells 
Th e  cells used in this s tudy  inc luded high 
and low mal ignant  f ib rosa rcoma lines ob-  
ta ined f ro m  a mur ine  f ib rosa rcoma  induced  
wi th  3 -me thy l cho l an th rene  in a C57B1/6 
mouse .  Th e  origin and character is t ics  o f  these  
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l ines  have  b e e n  d e s c r i b e d  p r e v i o u s l y  (Or r  e t  
a l . ,  1 9 7 8 a ;  V a r a n i  e t  a l . ,  1 9 7 9 ) .  N o r m a l  
m o u s e  e m b r y o  f i b r o b l a s t s  w e r e  a lso  u s e d  in  
t h i s  s t u d y .  T h e y  w e r e  o b t a i n e d  in  s u s p e n s i o n  
f r o m  M i c r o b i o l o g i c a l  A s s o c i a t e s  ( B e t h e s d a ,  
M D ) .  U p o n  a r r iva l  in  t h e  l a b o r a t o r y  t h e y  w e r e  
p l a t e d  in p l a s t i c  f l a sks  a n d  u s e d  d u r i n g  t h e  
f i r s t  p a s s a g e .  A l l  o f  t h e  ce l l s  w e r e  g r o w n  o n  
m e d i u m  1 9 9  s u p p l e m e n t e d  w i t h  10% f e t a l  
ca l f  s e r u m ,  1 0 0  u n i t s / m l  o f  p e n i c i l l i n  a n d  1 0 0  
# g / m l  o f  s t r e p t o m y c i n .  T h e  t u m o r  ce l l s  w e r e  
r o u t i n e l y  s u b c u l t u r e d  b y  t r y p s i n i z a t i o n .  H o w -  
ever ,  f o r  a s s a y  p u r p o s e s  t h e  ce l l s  w e r e  o b -  
t a i n e d  b y  w a s h i n g  in c o l d  H a n k s '  b a l a n c e d  
sa l t  s o l u t i o n  ( H B S S )  a n d  v i g o r o u s l y  s h a k i n g  
t h e  f l a sks .  
2.2. Chemotactic factors 
L a t h y r i t i c  c h i c k  c o l l a g e n  c h a i n s  w e r e  
k i n d l y  s u p p l i e d  b y  Dr .  A r n o l d  P o s t l e t h w a i t e  
o f  t h e  V e t e r a n s  A d m i n i s t r a t i o n  H o s p i t a l ;  
M e m p h i s ,  T N .  T h e y  w e r e  o r i g i n a l l y  p r e p a r e d  
as d e s c r i b e d  e l s e w h e r e  ( P o s t l e t h w a i t e  e t  a l . ,  
1 9 7 8 )  a n d  s o l u b i l i z e d  b y  d i s s o l v i n g  in 0 .5  M 
a c e t i c  a c id  (37°C)  t o  a c o n c e n t r a t i o n  o f  
5 m g / m l .  T h e  s o l u t i o n  was  t h e n  d i a l y z e d  a t  
r o o m  t e m p e r a t u r e  a g a i n s t  p h o s p h a t e - b u f f e r e d  
sa l ine  f o r  2 d a y s  w i t h  f r e q u e n t  c h a n g e s  o f  
b u f f e r .  T h e  s o l u b i l i z e d  c o l l a g e n  was  t h e n  
s t o r e d  a t  - - 2 0 ° C  u n t i l  u se .  
T h e s e  s y n t h e t i c  c o l l a g e n  p e p t i d e s ,  g lycy l -L -  
p r o p y l - L - h y d r o x y p r o l i n e  ( G P H ) ,  g l y c y l - L - h y -  
d r o x y p r o l i n e  ( G H )  a n d  L - p r o l y l h y d r o x y - L -  
p r o l i n e  (PHP)  w e r e  p u r c h a s e d  f r o m  S i g m a  
C h e m i c a l  C o m p a n y  (St .  L o u i s ,  M O )  a n d  p re -  
p a r e d  as 10  -3 M s o l u t i o n s  in d i m e t h y l  s u l f o x -  
ide .  F i n a l  d i l u t i o n s  w e r e  m a d e  in H B S S .  
T h e  C 5 - r e l a t e d  c h e m o t a c t i c  f a c t o r  was  p re -  
p a r e d  as  p r e v i o u s l y  d e s c r i b e d  f r o m  z y m o s a n -  
a c t i v a t e d  n o r m a l  h u m a n  s e r u m  ( N i l s s o n  e t  al . ,  
1 9 7 2 ) .  T h e  m a t e r i a l  w i t h  c h e m o t a c t i c  a c t i v i t y  
TABLE I 
Responses of metastasizing 
peptides and the C5-related 
and non-metastasizing fibrosarcoma cells and normal fibroblasts to collagen, collagen 
tumor cell chemotactic factor 
Chemotactic factor Responses in the Boyden chamber assay a and particle counter assay b 
Metastasizing Non-metastasizing Normal mouse 
fibrosarcoma fibrosarcoma fibroblasts 
Boyden Particle Boyden Particle Boyden Particle 
chamber counter chamber counter chamber counter 
Lathyrit ic chick 
collagen (1 mg/ml) 0 45  18 -+ 2 20 - 4 20 -+ 2 22 _+ 4 
GPH (10-8 M) 2 + 1  <5 19_+3 18_+2 19_+4 16+_3 
GH (10 -8 M) 1 + 1 <5 25 -+ 2 18 _+ 2 16 _+ 2 15 -+ 2 
PHP (10 -s M) 0 <5 1 -+ 2 <5 0 <5 
C5-derived factor 
(1 EDs0 ) 25_+ 2 17-+ 2 2 + 2 <5 0 <5 
a The Boyden chamber was run as described in our recent report  (Orr et al., 1978a). Values represent the average 
number of cells (-+ S.E.M.) counted in each of the three high power fields in each of three membranes. The number 
of cells counted in chambers to which HBSS alone was added have been subtracted. This value was normally 
between 15 and 25 cells per high power field. Each cell type was assayed in at least three occasions. One such 
experiment is shown. 
b The particle counter assay was run as described in our recent reports (Wass et al., 1980, 1981). Values represent 
the maximum percent drop (_+S.E.M.) in the number of cells counted by the particle counter.  Each value is the 
average of four experiments and in each experiment three values were obtained per point. Along with each 
treated sample of cells was run a sample of untreated cells. 
for leukocytes was treated by short-term tryp- 
sinization to produce maximal activity for the 
t u m o r  cells (Orr et al., 1978a). 
2.3. Analytical methods 
The standard Boyden chamber chemotaxis 
assay was performed as previously described 
(Orr et al., 1978a). In addition to using the 
standard Boyden chamber method,  we also 
used a particle counter assay to measure the 
interaction between the tumor  cells and 
chemotactic factors. This assay is based on 
the finding that  tumor cell swelling occurs in 
response to the chemotactic factors and that  
simultaneous to the swelling (and perhaps as 
a result of  swelling) the number of  cells in sus- 
pension counted by a particle counter tem- 
porarily decreases (Wass et al., 1980, 1981). 
3. Results 
Table I shows the pattern of  responsiveness 
of  all three cell types to the collagen<lerived 
and C5<lerived chemotactic peptides. It can 
be seen that  the normal fibroblasts and non- 
metastasizing fibrosarcoma cells had a similar 
pattern of  responsiveness. Both responded to 
the lathyritic chick collagen and to the colla- 
gen-derived peptides, GPH and GH, but did 
not respond to the C5 peptide. On the other 
hand, the metastasizing fibrosarcoma cells 
responded to the C5 peptide but  did not 
respond to the collagen or collagen-related 
peptides. None of  the cells responded to PHP. 
It can also be seen in Table I that  the results 
obtained with the two assays were consistent 
with one another.  
4. Discussion 
Several studies have shown that  normal hu- 
man fibroblasts are able to respond chemo- 
tactically to collagen~lerived peptides as well 
as to a number of  other factors (Postle- 
thwaite et al., 1976, 1978, 1979; Chiang et 
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al., 1978, Postlethwaite and Kang, 1980). 
The present study demonstrates that  normal 
mouse fibroblasts are also capable of  respond- 
ing to the same collagen<lerived peptides. In 
addition, it was found in this study that  a 
non-metastasizing line of  murine fibrosarcoma 
cells also responded to these factors. In con- 
trast, neither the normal fibroblasts nor the 
non-metastasizing fibrosarcoma cells demon- 
strate responsiveness to the C5~lerived tumor  
chemotactic peptide. The similarities between 
the normal fibroblasts and the low malignant 
fibrosarcoma cells in their responses to vari- 
ous chemotactic peptides would suggest some 
common membrane features. Whether the 
positive responses to the collagen peptides is 
only a marker of  the 'normal '  fibroblast sur- 
face or whether it has biological significance 
remains to be seen. It has been argued that  
the chemotactic response of  normal fibro- 
blasts to collagen contributes to the localiza- 
tion of  fibroblasts at sites of  wound healing 
(Postlethwaite et al., 1978). It could likewise 
be argued that  the ability of  the non-metasta- 
sizing tumor cells to respond to the collagen 
products may contribute to the prevention of  
their metastasizing. The universal presence of 
collagen throughout  the body would desensi- 
tize the cells. 
The lack of  response of  the metastasizing 
tumor  cells to the collagen peptides and their 
positive response to the C5 peptide indicate a 
clear functional difference between these cells 
on the one hand, and the non-metastasizing 
fibrosarcoma cells and normal fibroblasts on 
the other. Whether this functional difference 
is a result of  a major membrane alteration or 
of  a subtle alteration in structure remains to 
be seen. With regard to chemotactic respon- 
siveness, the metastasizing fibrosarcoma cells 
are very similar to polymorphonuclear leuko- 
cytes (Fernandez et al., 1978). It has been 
argued that  the response to C5<lerived pep- 
tides contributes to the ability of  these cells 
to metastasize in the same manner as the 
response in leukocytes contributes to their 
ability to localize at sites of  inflammation. 
Whatever the biological significance of 
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these chemotac t i c  responses,  the  pat terns  o f  
responsiveness exhibi ted by  the  normal  fibro- 
blasts and the  metastasizing and non-metas ta-  
sizing f ib rosarcoma cells clearly indicate two  
pa thways  o f  d i f ferent ia t ion.  They  clearly indi- 
cate that ,  in this regard, the  low malignant ,  
non-metas tas iz ing f ib rosarcoma cells have 
m u c h  more  in c o m m o n  with the  normal  fibro- 
blasts than  with the  highly malignant  metasta-  
sizing f ib rosarcoma cells ob ta ined  f rom the  
same parent  t umor .  
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